Subtype
Non-Invasive Urothelial Neoplasm
CI-CAN-00003434Explore in graph →
Non-malignant4 active trials
- NCIt
- C39854
Loading cancer entity…
Subtype
CI-CAN-00003434Explore in graph →
Clinical trials
12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02901548 | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | terminated | Phase 2 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 29, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Jul 29, 2022source: clinicaltrials